|
DOPEY1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.503500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.865600E-02 |
| Normal-vs-Stage2 |
2.154400E-02 |
| Normal-vs-Stage3 |
9.79650000000332E-05 |
| Normal-vs-Stage4 |
3.664500E-03 |
| Stage1-vs-Stage2 |
3.655200E-01 |
| Stage1-vs-Stage3 |
7.362900E-03 |
| Stage1-vs-Stage4 |
1.282360E-01 |
| Stage2-vs-Stage3 |
3.049200E-01 |
| Stage2-vs-Stage4 |
6.336800E-01 |
| Stage3-vs-Stage4 |
6.358800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.858400E-03 |
| Normal-vs-AfricanAmerican |
4.563400E-01 |
| Normal-vs-Asian |
5.188800E-01 |
| Caucasian-vs-AfricanAmerican |
2.464800E-01 |
| Caucasian-vs-Asian |
5.690300E-02 |
| AfricanAmerican-vs-Asian |
8.276800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.608380E-02 |
| Normal-vs-Female |
8.362300E-03 |
| Male-vs-Female |
9.352400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.099590E-01 |
| Normal-vs-Age(41-60Yrs) |
7.595000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.406200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.445500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.292850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.508340E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.098400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.506400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.521400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.270000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.44089999995789E-06 |
| Classical-VS-Follicular |
2.414000E-01 |
| Classical-VS-Other |
6.523600E-01 |
| Classical-VS-Normal |
6.369900E-02 |
| Tall-VS-Follicular |
6.582900E-03 |
| Tall-VS-Other |
1.055830E-01 |
| Tall-VS-Normal |
4.97950000011294E-07 |
| Follicular-VS-Other |
9.679000E-01 |
| Follicular-VS-Normal |
2.455900E-02 |
| Other-VS-Normal |
2.072400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.499600E-03 |
| Normal-vs-N1 |
1.283160E-01 |
| N0-vs-N1 |
3.375000E-01 |
|
|
